.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Dow
McKinsey
Cerilliant
Queensland Health
Merck
Johnson and Johnson
Fuji
Mallinckrodt
Boehringer Ingelheim

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Plasticizers for coating compositions
Abstract: A biocompatible plasticizer useful for forming a coating composition with a biocompatible polymer is provided. The coating composition may also include a biobeneficial polymer and/or a bioactive agent. The coating composition can form a coating on an implantable device. The implantable device can be used to treat or prevent a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.
Inventor(s): Pacetti; Stephen Dirk (San Jose, CA), Tang; Yiwen (Sunnyvale, CA), Hossainy; Syed Faiyaz Ahmed (Hayward, CA)
Assignee: Abbott Cardiovascular Systems Inc. (Santa Clara, CA)
Application Number:14/621,301
Patent Claim Types:
see list of patent claims
Compound; Device; Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Centocor Inc
REOPRO
abciximab
INJECTABLE; INJECTION1035750011994-12-22► Subscribe Abbott Cardiovascular Systems Inc. (Santa Clara, CA) Pacetti; Stephen Dirk (San Jose, CA), Tang; Yiwen (Sunnyvale, CA), Hossainy; Syed Faiyaz Ahmed (Hayward, CA) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
United States of America2009238854Sep 24, 2009
United States of America2015150989Jun 04, 2015
United States of America8980300Mar 17, 2015
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
US Department of Justice
Teva
Express Scripts
Baxter
Fuji
Harvard Business School
AstraZeneca
McKesson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot